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The regulated secretory pathway in neuroendocrine cells ends with the release of hor-
mones and neurotransmitters following a rise in cytosolic calcium. This process known as
regulated exocytosis involves the assembly of soluble N -ethylmaleimide-sensitive factor
attachment protein receptor (SNARE) proteins, the synaptic vesicle VAMP (synaptobrevin),
and the plasma membrane proteins syntaxin and SNAP-25. Although there is much evi-
dence suggesting that SNARE proteins play a key role in the fusion machinery, other cellular
elements regulating the kinetics, the extent of fusion, and the preparation of vesicle for
release have received less attention. Among those factors, lipids have also been proposed
to play important functions both at the level of secretory vesicle recruitment and late mem-
brane fusion steps. Here, we will review the latest evidence supporting the concept of the
fusogenic activity of lipids, and also discuss how this may be achieved. These possibilities
include the recruitment and sequestration of the components of the exocytotic machinery,
regulation of protein function, and direct effects on membrane topology.
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INTRODUCTION: A ROLE FOR LIPID IN EXOCYTOSIS?
Release of hormones from neuroendocrine cells occurs through
exocytosis, a process in which specialized vesicles (secretory gran-
ules) fuse with the plasma membrane in response to extrinsic
stimuli leading to elevated cytosolic calcium. Chromaffin cells
have proven to be a valuable model for unraveling the molecu-
lar mechanisms underlying this fundamental membrane fusion
event (1). In these cells, secretory granules are first transported
from the Golgi area to the cell periphery where they are then
docked at the plasma membrane in two apparent stages: a non-
primed (fusion incompetent) and a primed (fusion competent)
state. Details of the molecular machinery underlying some of
these steps have been described (2). For instance, once tethered to
the plasma membrane, docking of granules is mediated by solu-
ble N -ethylmaleimide-sensitive factor (NSF) attachment protein
receptors (SNAREs) found on granules (v-SNAREs) and on the
plasma membrane (t-SNAREs). Through coiled-coil interactions,
these proteins form a stable complex that provides the energy nec-
essary to pull membranes into close proximity rendering them
fusion competent (3). The mechanism of membrane fusion per se
is however an aspect that continues to be debated. SNAREs are
able to drive membrane fusion in vitro (4), but with relatively
slow kinetics suggesting that additional factors are required for
physiological membrane fusion. Recently, the SNARE accessory
protein Munc18 was shown to increase the speed of SNARE-
mediated fusion (5). Lipids, the prime constituents of the fusing
membranes, are also obvious candidates to accelerate the fusion
process. The first lipid firmly demonstrated to be critical for exocy-
tosis was phosphatidylinositol-4,5-bisphosphate [PtdIns(4,5)P2],
for review, see Ref. (6), and more recently fatty acids have been sug-
gested to play an important function in neurotransmitter release
from synaptic vesicles (7). Growing evidence also support a role
for cholesterol and phosphatidic acid (PA) during exocytosis, for
review, see Ref. (8). Hence, many observations are in agreement
with the notion that lipids contribute at different levels to exocyto-
sis. The issues now arising concern the precise step in the dynamic
exocytotic process in which a given lipid actually functions.
LIPIDS ARE INVOLVED THROUGHOUT THE SEQUENTIAL
STAGES UNDERLYING EXOCYTOSIS
CHOLESTEROL AND PHOSPHATIDYLSERINE FOR DEFINING
EXOCYTOSIS SITES
Cholesterol and sphingolipids cluster into discrete microdomains
in cellular membranes to form lipid ordered domains. This clus-
tering is triggered by secretagogues at the level of exocytotic
sites in chromaffin cells (9). Although cholesterol depletion by
methyl-β-cyclodextrin provided the initial evidence for a posi-
tive role of cholesterol in exocytosis (10), these experiments are
subjected to caution because of the brought structural role of
cholesterol in most cellular functions. More compelling evidence
supporting a direct role for cholesterol relies on both biochemical
and high-resolution imaging observations indicating that SNAREs
concentrate in cholesterol-dependent clusters (11). Additionally, a
cholesterol-sequestering agent, the polyene antibiotic filipin, that
is supposed to have less dramatic effects on membrane structures
than methyl-β-cyclodextrin, induces a dose-dependent inhibition
of catecholamine secretion and the release from the plasma mem-
brane of annexin A2 which participates in the formation and/or
stabilization of GM1-PtdIns(4,5)P2 enriched domains required
for granule recruitment (9, 12). Altogether these findings support
the notion that cholesterol is involved in the spatial definition of
exocytotic sites.
In the plasma membrane, phosphatidylserine (PS) mostly
resides in the inner cytoplasmic leaflet. In non-apoptotic cells,
several biological functions are accompanied by a disruption of
this phospholipid asymmetry resulting in the externalization of
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PS on the outer leaflet of the plasma membrane. This is the case
for calcium-regulated exocytosis in neuroendocrine chromaffin
and PC12 cells (13, 14). However the functional importance of PS
scrambling for secretion is still under debate and the precise kinet-
ics of this translocation is not established. An interesting possibility
lies in the fact that PS contributes substantially to the negative
charge of the inner leaflet of the plasma membrane. Consequently,
PS scrambling at exocytotic sites could modify the protein/lipid
interactions occurring during either the course of exocytosis or
the early phases of endocytosis, as suggested recently (15).
PHOSPHOINOSITIDES FOR PRIMING SECRETORY VESICLES
Phosphoinositides are a class of phospholipids characterized by an
inositol head group that can be phosphorylated on the three, four,
and five positions to generate seven distinct species key in cell sig-
naling and trafficking. Much of the work carried out on exocytosis
has focused on the role played by PtdIns(4,5)P2. Indeed a number
of pioneer studies indicated that PtdIns(4,5)P2 positively modu-
lates secretion in neuroendocrine cells (16–18). Using patch clamp
experiments on intact chromaffin cells and in parallel analyzing
images of plasma membrane lawns, it was subsequently shown that
over-expression of the kinase that generates PtdIns(4,5)P2 causes
an increase in the plasmalemmal PtdIns(4,5)P2 level and secretion,
whereas over-expression of a membrane-tagged PtdIns(4,5)P2
phosphatase eliminates plasmalemmal PtdIns(4,5)P2 and inhibits
secretion (19). Thus, the balance between the generation and
degradation rates of the plasmalemmal PtdIns(4,5)P2 directly reg-
ulates the extent of exocytosis from chromaffin cell. Using the
phosphatidylinositol 3-kinase inhibitor LY294002, a correlation
between the level of the plasma membrane PtdIns(4,5)P2 and
the size of the primed vesicle pool was found (19, 20). Wen et
al. (21) further demonstrated that selective inhibition of phos-
phatidylinositol 3-kinase delta isoform was responsible for this
effect. Importantly, such an inhibition promotes a transient rise
in PtdIns(4,5)P2 that was sufficient to mobilize secretory vesi-
cles to the plasma membrane via activation of the small GTPase
Cdc42 and actin polymerization. More recently, a functional link
between PtdIns(4,5)P2 signaling and secretory vesicle dynamics
through de novo remodeling of the actin cytoskeleton was also
described (22). These observations are consistent with a function
of PtdIns(4,5)P2 as an acute regulator of secretion. PtdIns(4,5)P2
seems to lie in a key position controlling the size and refilling
rate of the primed vesicle pools, but not the fusion rate constants
per se. In line with this model, we recently reported that the HIV
PtdIns(4,5)P2-binding protein Tat is able to penetrate neuroen-
docrine cells and accumulate at the plasma membrane through
its binding to PtdIns(4,5)P2. By sequestering plasma membrane
PtdIns(4,5)P2, Tat alters neurosecretion, reducing the number of
exocytotic events without significantly affecting kinetic parame-
ters (fusion pore opening, dilatation, and closure) of individual
events (23).
Other phosphoinositides seem to act as signaling or recruit-
ment factors to prime secretory vesicles for exocytosis. For
instance, experiments carried out on permeabilized chromaffin
cells reveal that PtdIns(3)P located on a subpopulation of chro-
maffin granules positively regulates secretion (21, 24). Extending
these observations, PIKfyve kinase that produces PtdIns(3,5)P2
from PtdIns(3)P on secretory granules was shown to negatively
affect exocytosis (25). Hence, these studies highlight a com-
plex regulation of neuroexocytosis by phosphoinositides, with
PtdIns(4,5)P2 and PtdIns(3)P being essential factors promoting
ATP-dependent priming in neurosecretory cells. It is intriguing
that PtdIns(3,5)P2 displays an opposite effect, but reveals how
fine-tuning of exocytosis by phosphoinositides could potentially
control the number of vesicles undergoing priming in response to
a stimulation.
PHOSPHATIDIC ACID FOR FUSION
The local formation of PA is a recurring theme in intracellular
membrane traffic and its involvement in regulated exocytosis has
been suggested in various models, including neuroendocrine cells
(14, 26). The development of molecular tools has enabled the
identification of phospholipase D1 (PLD1) as the key enzyme
responsible for PA synthesis during exocytosis (14, 27). Capaci-
tance recordings from chromaffin cells silenced for PLD1 suggest
that PLD1 controls the number of fusion competent secretory
granules at the plasma membrane without affecting earlier recruit-
ment or docking steps, leading to the idea that PA acts directly in
membrane fusion (28). In agreement with this concept, a molec-
ular sensor for PA revealed local PA accumulation at the plasma
membrane near morphologically docked granules at sites of active
exocytosis (28).
OTHER LIPIDS
Various other lipids are suspected to take part in regulated exo-
cytosis. Although most of them have been implicated based on
in vitro membrane fusion assays, some have also been studied in
neuroendocrine cells. For instance, diacylglycerol (DAG) increases
stimulus-coupled secretion by recruiting vesicles to the immedi-
ately releasable pool through the regulation of the vesicle prim-
ing protein Munc13-1 (29). Furthermore by activating protein
kinase C, DAG may modulate the phosphorylation level of vari-
ous proteins contributing or regulating the exocytotic machinery,
including SNAP-25 and Munc18 (30, 31). Modulating PS levels
also directly affects the rate of exocytosis in PC12 cells. Although
it is likely that long term provision of high level of PS (incubation
with 100µM for 48 h or over-expression of PS synthase) may affect
numerous key cellular functions altogether, it was shown that PS
influences exocytosis by enhancing fusion pore opening and slow-
ing fusion pore dilatation in PC12 cells (32). The kinetic changes
in exocytosis resulting from elevated PS levels were shown to be
unlikely the reflection of an indirect action of PS on Ca2+ chan-
nels, or vesicle size or number, or the levels of some of the major
exocytosis proteins, but may be the consequence of synaptotag-
min binding to PS (32). Finally, arachidonic acid produced from
different phospholipids by phospholipase A2 and from DAG by
DAG-lipase potentiates exocytosis from chromaffin cells (33, 34).
LIPIDS AS RECRUITING COMPONENTS OF THE EXOCYTOTIC
MACHINERY
Within membranes, the ability of microdomains to sequester
specific proteins and exclude others makes them ideally suited
to spatially organize cellular pathways. Cholesterol-enriched
microdomains seem to concentrate components of the exocy-
totic/fusion machinery. For instance, numerous studies of the
Frontiers in Endocrinology | Neuroendocrine Science September 2013 | Volume 4 | Article 125 | 2
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ammar et al. Fusogenic lipids
distribution of SNARE proteins in various cell types suggest that
SNAREs partially associate with detergent resistant, cholesterol-
enriched microdomains (11). Palmitoylation appears to be the
major targeting signal in these microdomains, as in the case of
SNAP-25, although it is likely that other elements contribute to
the enrichment of constituents of the exocytotic machinery within
these cholesterol microdomains. However despite intense research
there is still little known about what lipid or protein molecules are
actually present at sites of exocytosis.
Up to 20 proteins potentially involved in regulated exocyto-
sis have been reported to bind PtdIns(4,5)P2 (35). These include
synaptotagmin (36), syntaxin (37), Ca2+-dependent activator pro-
tein for secretion (CAPS) (38), and members of the PLD signaling
pathway (16, 39, 40). Using immunogold labeling of plasma mem-
brane sheets combined with spatial point pattern analysis, we
recently observed that PtdIns(4,5)P2 microdomains co-localize
with SNARE clusters and docked secretory granules (12). Translo-
cation of the PtdIns(4,5)P2-binding protein annexin A2 to the
plasma membrane following cell stimulation is a hallmark of chro-
maffin cell exocytosis (41). Annexin A2 plays an essential role
in calcium-regulated exocytosis by promoting PtdIns(4,5)P2 and
cholesterol-enriched domains containing SNAREs in the vicinity
of docked granules (9, 12). Altogether these observation raise the
notion that functional exocytotic sites defined by specific lipids
such as cholesterol, GM1, and PtdIns(4,5)P2 are able to recruit
and sequester components to build a machine that drives fast and
efficient membrane fusion (Figure 1).
Molecular details of how PtdIns(4,5)P2 forms a platform for
vesicle recruitment have recently been proposed (42). In this
study, synaptotagmin-1 was shown to interact independently of
Ca2+ with the polybasic linker region of syntaxin-1A already
associated with PtdIns(4,5)P2 at the plasma membrane. When
then triggered by Ca2+, this interaction allows the Ca2+-binding
sites of synaptotagmin-1 to bind PS in the vesicle membrane,
thereby bridging the vesicle membrane close enough for SNARE
assembly and subsequent membrane fusion. Interestingly, this
polybasic juxtamembrane domain of syntaxin-1A which binds
PtdIns(4,5)P2 has also been shown to tightly bind both PA (37)
and PtdIns(3,4,5)P3 (43). Like PtdIns(4,5)P2, these anionic lipids
can probably recruit syntaxin-1A, and it is tempting to propose
that the recruitment of syntaxin isoforms may depend on the type
of lipid present. Furthermore, the fact that these lipids can be
quickly converted into different forms using kinases, lipases, and
phosphatases, such a protein-recruiting mechanism offers a sup-
plementary level of control to adapt the exocytotic machinery to
the physiological demands put on the cell. Finally, using super-
resolution optical techniques and fluorescence lifetime imaging
microscopy, it was shown that distinct t-SNARE intermediate
states on the plasma membrane can be patterned by the underlying
lipid environment (44). Undoubtedly these high-resolution imag-
ing techniques will be useful to determine how lipids contribute
to the organization of the exocytotic platform.
LIPIDS AS REGULATORS OF THE EXOCYTOTIC MACHINERY
PtdIns(4,5)P2 directly binds to a large subset of proteins from
the exocytotic machinery. In vitro experiments revealed that at
physiological concentrations PtdIns(4,5)P2 regulates exocytosis by
recruiting priming factors such as CAPS, which facilitate SNARE-
dependent liposome fusion (45). PtdIns(4,5)P2 is also a necessary
cofactor for PLD1 activity and PA synthesis during exocytosis (39).
Finally, PtdIns(4,5)P2 controls actin polymerization by modulat-
ing the activity and targeting of actin regulatory proteins. Indeed
the activity of the actin-binding proteins scinderin and gelsolin,
two F-actin severing proteins that are constituents of the exocy-
totic machinery, is regulated by PtdIns(4,5)P2 (46). A transient
increase in PIP2 levels is sufficient to promote the mobilization
and recruitment of secretory vesicles to the plasma membrane
(22). PIP2 therefore links exocytosis and the actin cytoskeleton by
FIGURE 1 | Model highlighting the importance of lipids for membrane
fusion. Exocytotic sites defined as cholesterol, GM1, PtdIns(4,5)P2, and PA
enriched microdomains recruit constituents of the docking/fusion machinery
and create membrane curvature of the inner leaflet of the plasma membrane
prior to promote membrane merging. PtdIns(4,5)P2 and PA may also regulate
SNARE complex assembly and structure.
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coordinating the actin-based delivery of secretory vesicles to the
exocytotic sites.
Diacylglycerol production through hydrolysis of PtdIns(4,5)P2
by phospholipase C is mandatory for exocytosis (47). DAG is
essential in the priming of exocytosis, owing to the activation of
protein kinase C and Munc13, which then modulate the function
of syntaxin-1A (29). It is worth to mention that up to 10 differ-
ent DAG-kinases may also produce DAG from various subcellular
pools of PA during exocytosis. Finally DAG is further hydrolyzed
by DAG lipases to liberate fatty acids and monoacylglycerols. This
pathway is essential for exocytosis as inhibition of DAG lipase
blocks exocytosis (48).
Several constituents and regulators of the exocytotic machin-
ery have also been shown to bind to PA, including small
GTPases, NSF, and syntaxin-1A (49). PA directly activates these
proteins, but evidence that this activation directly contributes
to exocytosis remains scarce. PA is also an essential cofactor
of phosphatidylinositol-4-phosphate 5-kinase, which produces
PtdIns(4,5)P2, suggesting a possible positive feedback loop in the
synthesis of PA and PtdIns(4,5)P2 (50). Although no direct evi-
dence in neuroendocrine systems have shown that PA directly
regulates the assembly or the function of the minimal fusion
machinery, in vitro reconstituted fusion assays with purified yeast
vacuolar SNAREs do so. Indeed experiments performed in a
complex reconstituted system including the SNARE chaperones
Sec17p/Sec18p, the multifunctional HOPS complex including a
subunit of the Sec1-Munc18 family and vacuolar lipids suggest
that PA is equally essential for SNARE complex assembly and for
fusion. PA has been proposed to facilitate functional interactions
among SNAREs and SNARE chaperones (Figure 1). Interestingly,
in this system, PA could not be replaced by either lipids with small
headgroups, such as DAG or acidic lipids, like PS or PI (51).
Arachidonic acid has been described to directly promote the
assembly of syntaxin-3 with SNAP-25 and the formation of the
ternary SNARE complex (52). Interestingly, omega-3 and omega-
6 fatty acids, which play important roles in human health, have
be shown to recapitulate this in vitro effect of arachidonic acid
on SNARE complex formation, suggesting that syntaxins may
represent crucial targets of polyunsaturated lipids (52). In other
words, polyunsaturated lipids may physiologically regulate SNARE
complex assembly and thus exocytosis. Along this same line, sphin-
gosine a releasable backbone of sphingolipids, activates vesicu-
lar synaptobrevin facilitating the assembly of SNARE complexes
required for membrane fusion (53). It is however important to
note that the effects of arachidonic acid and sphingosine observed
in these studies are all achieved near or at the CMC value for these
lipids, treatments that may also lead to membrane disorganization
like detergent action.
LIPIDS AFFECT MEMBRANE TOPOLOGY DURING
MEMBRANE FUSION: THE CONCEPT OF FUSOGENIC LIPIDS
The most widely accepted model for membrane fusion, the stalk
pore model proposes that the merging of cis contacting monolay-
ers gives rise to a negatively curved lipid structure called a stalk.
The structure of this stalk depends on the composition of the cis
monolayers (the outer leaflet of the vesicle and the inner leaflet
of the plasma membrane). This model implies that cone-shaped
lipids such as cholesterol, DAG, or PA, which have intrinsic neg-
ative curvatures, in the cis leaflets of contacting bilayers would
enhance membrane fusion (54). Vice versa inverted cone-shaped
lipids (such as PS, gangliosides, or lysophospholipids) should pre-
vent membrane fusion in the cis leaflets, but promote fusion when
present in the outer leaflets (54). Interestingly, GM1 was found
enriched in the outer leaflet of the plasma membrane at the sites of
exocytosis in stimulated chromaffin cells (9). These GM1 domains
may induce positive membrane curvature in the outer leaflet (55),
thereby promoting fusion (Figure 1). Reconstituted fusion assays
and direct addition of lipids on cultured cells validate the con-
cept that PA, DAG, and cholesterol might promote membrane
fusion by changing the spontaneous curvature of membranes
[reviewed in (8)]. At physiological concentrations, PtdIns(4,5)P2
inhibits SNARE-dependent liposome fusion (45), most likely due
to its intrinsic positive curvature-promoting properties. However,
PtdIns(4,5)P2 has been described to be converted from an inverted
cone-shaped structure to a cone-shaped form in the presence of
calcium (56). Thus, in stimulated cells, a local accumulation of
PA and PtdIns(4,5)P2 at granule docking sites where GM1 is in
the outer leaflets may well have a synergistic effect on membrane
curvature and promote fusion (Figure 1). In an alternate mode of
changing membrane topology, synaptotagmin has been proposed
to facilitate membrane fusion by phase separating PS, a process
that is expected to locally buckle bilayers and disorder lipids due
to the curvature tendencies of PS (57). It is worth to mention that
most of lipid mentioned in this review, also have the ability to flip
from one leaflet to another. How this flipping is regulated and how
it affects curvature remains an unsolved issue. However, it is likely
that the ability of these lipids to interact with the fusion machinery
largely controls these flipping properties.
CONCLUSION
As genuine components of the exocytotic machinery, lipids have
several advantages over proteins for this task: lipids can directly
change the intrinsic fusion properties of membranes, recruit,
and/or activate a large number of different proteins to create a
local environment in which exocytosis takes place (Figure 1). As
illustrated in this review, a given lipid can play multiple functions,
acting either individually or successively or even simultaneously
in concert with other lipids. At the same time, the rapid enzymatic
production and degradation of lipids at exocytotic sites allows the
cell to remain flexible: by changing the lipid levels, physiological
function can be modified within seconds or minutes without the
need for protein synthesis or degradation. Over the last decade,
in vitro reconstituted membrane fusion combined with precise
methods to quantify specific lipid species and improved molecular
and pharmacological tools to manipulate cellular levels of a given
lipid, have lead to a better understanding of the capacities of lipids
to promote exocytosis at different steps of the process. For different
kinds of vesicles in different cell types, it is likely that the local lipid
environment may differentially regulate fusion pore formation,
enlargement, and duration, which may in part explain the great
variety of fusion kinetics observed in vivo. Finally, lipids could also
contribute to the tight coupling between exocytosis and the early
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stages of membrane retrieval and endocytosis as highlighted in
a review of this issue (Houy et al., submitted). Undoubtedly, the
next challenge will be to follow individual lipid dynamics at the
speed of pore formation and expansion.
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